391.17001 USD
0.33
0.08%
Last update Dec 16, 3:59 PM EST
Post-market
Day range
388.54001
399.57001
Previous close
391.5
Open
390.64999
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
391.17
0.33
0.08%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 2.2B 1.8B 1.0B 844.3M
Cost of revenue 323.4M 310.4M 168.8M 140.1M
Gross profit 1.9B 1.5B 868.6M 704.1M
Operating expense
Research & development 1.1B 1.0B 883.0M 792.2M
Selling general and admin 975.5M 795.6M 770.7M 620.6M
Other operating expenses
Operating income -176.9M -282.2M -785.1M -708.7M
Non operating interest income
Income 122.0M 95.6M 24.8M 1.6M
Expense 141.9M 121.2M 156.0M 143.0M
Other income expense -180.6M -125.7M -210.8M -2.1M
Pretax income -377.4M -433.5M -1.1B -852.1M
Tax provision -99.2M 6.7M 4.2M 680K
Net income -278.2M -440.2M -1.1B -852.8M
Basic EPS -2.2 -3.5 -9.3 -7.2
Diluted EPS -2.2 -3.5 -9.3 -7.2
Basic average shares 127.7M 124.9M 121.7M 118.5M
Diluted average shares 127.7M 124.9M 121.7M 118.5M
EBITDA -5.1M -107.3M -680.9M -636.7M
Net income from continuing op. -278.2M -440.2M -1.1B -852.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 1 hour 28 minutes

18:32
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).